Hope for a cure for cancer - BZKF study registry bundles around 1,000 studies
Cancer patients can find online access to innovative therapies and support services - targeted and close to home
When a cancer diagnosis turns life upside down, many patients begin an often long journey through treatment, uncertainty and questions. In addition to regular therapy, clinical trials offer an important opportunity: they provide access to new, promising treatment options - often years before they become widely available. To make it easier for patients in Bavaria to find their way to such studies, the Bavarian Center for Cancer Research (BZKF) has set up a central study registry for Bavaria. Since its launch in November 2022, the service has been growing steadily - around 1,000 clinical oncology studies are now recorded and available to all interested parties via the website studies.bzkf.de accessible. In order to facilitate access to these studies for patients and doctors, more than 1,700 contact details for the currently recruiting studies are available in the BZKF study register is available.
Orientation in a difficult time
At the launch of the project in 2022, Science Minister Markus Blume emphasized the importance of the study registry as a "navigator" for those affected. The study registry serves as a valuable orientation aid in an often stressful phase of life. The study register allows studies to be filtered according to disease, place of residence or type of treatment - simply and clearly. Anyone wishing to be included in a study can find out in advance about the requirements and find out at which clinics the respective study is being conducted.
Hope through cancer research
"Whether new drugs, help against side effects or psychological support - behind every study is potential progress. Trials can mean real opportunities for patients. Anyone who is unsure about finding suitable studies should ask the treatment team for help - because doctors are also called upon to actively use and pass on such information," says Prof. Dr. Claus Belka, Deputy Director of the BZKF and Director of the Clinic for Radiotherapy at LMU Klinikum München.
Early clinical study unit for Bavaria
"The development of new drugs and therapies is based on innovative preclinical research and clinical trials. The Early Clinical Trial Units (ECTU) of the BZKF play a decisive role here by enabling the safe application of experimental cancer treatment. The BZKF trial registry provides a clear and comprehensible overview of the various trials," explains Dr. Maria-Elisabeth Goebeler, Head Senior Physician of the Interdisciplinary Study Center with ECTU.
Find out more now
The study register atstudies.bzkf.de is intended to show those affected new perspectives. Talk to your attending physician or use the BürgerTelefonKrebsservice on the free telephone number 0800 85 100 80 to ask questions about cancer. If you have any questions about clinical trials, you can contact the ECTU team by e-mail at BZKF_ECTU_Koordination@ukw.de .
